Company attributes
Venture Capital Firm attributes
Other attributes
HBM BioCapital, or HBM Healthcare Investments, is a venture capital company that finances companies related to human medicine, biotechnology, medical technology, and diagnostics sectors. Founded 2001 in Zug, Switzerland, this venture capital firm invests in late stage ventures and private equity. It usually funds venture rounds and debt financing. Its portfolio companies include 4TEEN4 Pharmaceuticals, Vivoryon Therapeutics, Arcutis Biotherapeutics, Turning Point Therapeutics, and ObsEva. As of January 2020, the company had 36 exits and 123 investments. The primary products of HBM BioVentures' portfolio companies are either at an advanced stage of development or already available on the market. HBM BioVentures has a broad shareholder base and is listed on the SIX Swiss Exchange (ticker: HBMN).
